SCHEMBL3848199

SCHEMBL3848199

c1ccc(C(c2ccccc2)(c2ccccc2)n2ccc(-c3ccc4ncnc(N5CC[N]CC5)c4c3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 19/20 0.45
CYP1A2 P05177 18/20 0.45
ALDH1A1 P00352 13/20 0.45
CLK4 Q9HAZ1 12/20 0.45
LMNA P02545 10/20 0.45
HIF1A Q16665 9/20 0.45
MAPK1 P28482 9/20 0.45
TSHR P16473 7/20 0.45
MEN1 O00255 6/20 0.45
KMT2A Q03164 6/20 0.45
USP2 O75604 5/20 0.45
CYP2C19 P33261 12/20 0.45
CYP2D6 P10635 7/20 0.45
HSD17B10 Q99714 3/20 0.45
TP53 P04637 2/20 0.45
ALOX15 P16050 2/20 0.45
HPGD P15428 5/20 0.43
KDM4E B2RXH2 5/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAPT P10636 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846607 0.89 CYP3A4 (0.59) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL3852147 0.84 RPS6KB1 (0.48) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL3852907 0.82 CYP3A4 (0.43) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL3852434 0.82 ACHE (0.52) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL3855143 0.79 CYP3A4 (0.40) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL3855018 0.76 PDGFRB (0.45) CYP3A4TSHRTP53HPGDSMN1; SMN2
SCHEMBL3845891 0.71 ACHE (0.47) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL3846795 0.71 CYP1A2 (0.59) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL5852369 0.69 CYP1A2 (0.43) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL2203931 0.69 PTK2 (0.69) LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed